Page last updated: 2024-08-17

edetic acid and Carcinoma, Neuroendocrine

edetic acid has been researched along with Carcinoma, Neuroendocrine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Buck, AK; Deschler-Baier, B; Fassnacht, M; Hartrampf, PE; Hasenauer, N; Higuchi, T; Pomper, MG; Rowe, SP; Werner, RA1
Arora, S; Bal, C; Damle, NA; Dattagupta, S; Nalli, H; Parida, GK; Singhal, A1
Bardet, S; Ciappuccini, R; Edet-Sanson, A; Gauthé, M; Saguet-Rysanek, V1

Other Studies

3 other study(ies) available for edetic acid and Carcinoma, Neuroendocrine

ArticleYear
Visualization of Tumor Heterogeneity in Advanced Medullary Thyroid Carcinoma by Dual-Tracer Molecular Imaging: Revealing the Theranostic Potential of SSTR- and PSMA-Directed Endoradiotherapy.
    Clinical nuclear medicine, 2022, Jul-01, Volume: 47, Issue:7

    Topics: Carcinoma, Neuroendocrine; Edetic Acid; Gallium Radioisotopes; Humans; Male; Middle Aged; Oligopeptides; Positron Emission Tomography Computed Tomography; Precision Medicine; Prostatic Neoplasms; Radiopharmaceuticals; Thyroid Neoplasms

2022
Recurrent Medullary Thyroid Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT: Exploring New Theranostic Avenues.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:5

    Topics: Adult; Carcinoma, Neuroendocrine; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Male; Neoplasm Recurrence, Local; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms

2018
Thyroid Incidentaloma on 18F-fluorocholine PET/CT and 68Ga-PSMA PET/CT Revealing a Medullary Thyroid Carcinoma.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:8

    Topics: Aged; Carcinoma, Neuroendocrine; Choline; Edetic Acid; Gallium Isotopes; Gallium Radioisotopes; Humans; Incidental Findings; Male; Oligopeptides; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thyroid Neoplasms

2019